Drug intelligence / Profile preview

2,5-dideoxy-2,5-imino-d-glucitol

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

2,5-Dideoxy-2,5-imino-D-glucitol (DGDP or DDI) is a synthetic iminosugar and carbohydrate analog in which the ring oxygen of glucitol is replaced by a nitrogen atom. It is structurally derived from glucitol (sorbitol) and belongs to the class of pyrrolidines. DGDP acts as a potent inhibitor of glycohydrolases and glycosidases—enzymes responsible for breaking down carbohydrates—by binding to their active sites. Its primary target includes xylose isomerase found in certain bacteria. This inhibition can disrupt normal carbohydrate metabolism and has been explored for potential therapeutic applications such as pharmacological chaperoning in lysosomal storage disorders like Gaucher disease[3][5]. The compound was first isolated from Stemona tuberosa but is now synthetically produced[3].

Other names
2,5-Anhydro-2,5-imino-D-glucitol(2R,3R,4R,5S)-2,5-bis(hydroxymethyl)pyrrolidine-3,4-diol132295-44-4
02

Targets

XI (Xylose isomerase)

Beyond the preview

Go deeper on 2,5-dideoxy-2,5-imino-d-glucitol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,5-dideoxy-2,5-imino-d-glucitol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call